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Purpose: In elderly patients with chronic limb-threatening ischemia (CLTI), there is little 
scientific understanding of the long-term changes of quality of life (QoL) and health status 
(HS) after treatment. The primary goal of this study was to provide long-term QoL and HS 
results for elderly CLTI patients after therapy. Treatments consisted of endovascular revas-
cularization, surgical revascularization, or conservative treatment. Furthermore, the aim of 
this study was to identify the distinctive trajectories of QoL and HS.
Patients and Methods: CLTI patients aged ≥70 years were included in a prospective 
observational cohort study with a two-year follow-up. The WHOQOL-BREF was used to 
asses QoL. The 12-Item Short Form Health Survey was used to measure HS. The QoL and 
HS scores were compared to the scores in the general elderly Dutch population. Latent class 
trajectory analysis was used.
Results: A total of 195 patients were included in this study. After two years, in all treatment 
groups patients showed significantly higher physical QoL score compared to baseline and there 
was no significant difference with the corresponding values in the elderly Dutch population. In 
the latent class trajectory analysis, there were no overlapping risk factors for poorer QoL or HS.
Conclusion: This study shows that QoL levels in surviving elderly CLTI patients in the 
long-term do not differ from the corresponding values for elderly in the general population. 
There were no disparities in sociodemographic, clinical and treatment characteristics asso-
ciated with poorer QoL and HS. This study was carried out to encourage further analysis of 
the influence of biopsychosocial characteristics on QoL and HS in elderly CLTI patients.
Keywords: quality of life, health status, peripheral arterial disease, frail elderly, chronic 
limb-threatening ischemia
Introduction
The end stage of peripheral arterial disease is represented by chronic limb-threaten-
ing ischemia (CLTI). This disease is characterized by ischemic rest pain and/or 
tissue necrosis.1–3 CLTI diminishes quality of life (QoL) considerably and is 
associated with high mortality and morbidity rates.4–7 Revascularization (surgical 
or endovascular) is the cornerstone in the treatment of CLTI patients.1 However, 
scientific data is scarce to determine the best revascularization management in 
elderly (aged ≥70 years) CLTI patients.6–8 Moreover, revascularization is not 
always an option in frail elderly patients. In these patients, conservative treatment 
is a possible approach.9–11 However, objective clinical outcome measures of con-
servative treatment are poor.
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Lately, primary end points of treatment for CLTI have 
changed from clinical outcome, such as bypass patency 
and survival, to patient-reported outcome measures, most 
prominently QoL and health status (HS). Some research 
has been carried out on the long-term changes of these 
patient-reported outcome measures.12,13 Still, there is little 
scientific understanding of the long-term changes of QoL 
and HS after the treatment of elderly CLTI patients.13,14
Poorer QoL and HS over time can be associated with 
patient characteristics.15 The course of a measured vari-
able over time, such as QoL and HS, is called a trajec-
tory. Latent class trajectory analysis is used to measure 
the relationship between distinctive trajectories and socio-
demographic and clinical variables. In elderly CLTI 
patients, it is unclear which of these variables can influ-
ence the course of QoL and HS. Intermittent claudication 
(IC) is also a peripheral arterial disease and sometimes a 
precursor of CLTI. In IC patients, we know that poorer 
HS is associated with younger age, female sex, cardiac 
disease, worsening ankle-brachial index and not having a 
partner.17–20 To our knowledge, no studies have focused 
on the course of elderly CLTI patients’ QoL or HS after 
treatment. In elderly CLTI patients, we expect high age, 
tissue loss (eg Rutherford 5/6) and comorbidities to result 
in poorer QoL and HS. Insight in variables, that can 
influence the QoL and HS trajectories of elderly CLTI 
patients, gives health-care providers the opportunity to 
monitor specific patients more carefully. As a result of 
insufficient information concerning these trajectories, 
health-care providers are restricted in making evidence- 
based decisions.
The primary goal of the present study was to provide 
long-term QoL and HS results for elderly CLTI patients after 
primary therapy: endovascular revascularization, surgical 
revascularization, or conservative treatment. The QoL and 
HS scores of this study’s elderly sample were compared to 
the normal scores in the general elderly population. The 
second goal was to identify within the entire CLTI patient 
group distinctive trajectories of QoL and HS, followed by an 
assessment of the clinical and sociodemographic variables 
associated with each trajectory.
Patients and Methods
In this prospective observational cohort study, elderly 
CLTI patients were included between January 2012 and 
February 2016 in two hospitals.11 Inclusion criteria were 
diagnosis with CLTI and an age of 70 years or older. 
Because of the use of questionnaires, patients with a lack 
of Dutch language skills and cognitive impairment were 
excluded. Patients treated for, or with, a recent diagnosis 
of malignancy and patients undergoing primary major 
lower extremity amputation were also excluded. A formal 
written consent for ethical approval was not required 
according to the criteria of the Central Committee on 
Research Involving Human Subjects. The institutional 
review board (AMOA) approved this study due to its 
observational nature.11 This study was conducted in accor-
dance with the Declaration of Helsinki.
After careful consideration of standard diagnostics (eg 
duplex ultrasound, computed tomographic angiography, 
and/or magnetic resonance angiography) in the outpatient 
clinic and The Transatlantic Inter-Society Consensus 
(TASC II) classification, a panel of experts recommended 
each patient a particular treatment in a weekly multidisci-
plinary vascular conference.11 The recommendation of 
treatment was based on current clinical practice in addition 
to the patient’s condition. As reported previously,11 the 
treatment options were endovascular revascularization, 
surgical revascularization, or conservative therapy (local 
wound care, antibiotics, and analgesics with or without 
minor amputation).
At patient inclusion, sociodemographic and several 
clinical characteristics were obtained from each patient. 
Sociodemographic characteristics included age, sex, mar-
ital status, educational level and level of independence (eg 
independent, home with help, nursing home or care facil-
ity). Clinical characteristics were Rutherford classification, 
current smoking, and chronic comorbidities (renal impair-
ment, diabetes mellitus, cardiac disease). During a period 
of 24 months, follow-up measurements were performed at 
five to seven days, six weeks, six months, 12 months, and 
24 months after the initial therapy. At baseline and at each 
follow-up moment, patients completed the WHOQOL- 
BREF questionnaire to determine QoL and the 12-Item 
Short Form Health Survey (SF-12) to measure HS.16,17 HS 
questionnaires evaluate perceived physical, psychological, 
and social functioning. They assess patients’ daily activ-
ities and only provide an objective assessment of function-
ing, provided by the patients’ themselves.18–21 QoL 
questionnaires are a subjective appraisal of physical, psy-
chological, and social functioning. Hence, QoL concerns 
patients’ satisfaction with functioning.22 The treatment 
course (eg treatment, complications of treatment, time in 
hospital, time of amputation, time of death, etc) was also 
duly noted during follow-up.
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Statistical Analysis
Latent class trajectory analysis is a statistical method for 
identifying unobservable (eg latent) subgroups within a 
population based on the population’s pattern of answers 
on categorical and continuous observed variables. With 
latent class trajectory analysis, a prediction model why 
patients fall into certain subgroups can be created. Latent 
class trajectory analysis was used to classify patients into 
distinctive subgroups, each showing a unique QoL or HS 
trajectory over the two-year follow-up.23 Latent class 
trajectory analyses were performed separately for the 
following outcomes: overall QoL, physical QoL, physio-
logical QoL, physical HS, and psychological HS. For 
each outcome, models varying from one to eight distinc-
tive trajectory classes (eg similar scoring pattern on the 
measured variable) were estimated. The relative fit mea-
sures Akaike’s Information Criterion (AIC), Bayesian 
Information Criterion (BIC), and AIC3 were used to 
define the optimal number of classes.24 If there was any 
inconsistency in the conclusions provided by these fit 
measures, we chose the number of classes that showed 
the best fit according to AIC3, as this fit measure was 
shown to perform best in selecting the optimal number of 
classes.25 After the best fitting model was selected, the 
associations between latent trajectory class membership 
and the clinical and sociodemographic covariates could 
be determined using a multinomial logistic regression 
analysis. Missing values in the outcome variables were 
directly handled in the latent class model through full 
information maximum likelihood estimation. Latent gold 
5.0 was used both to fit the latent class models and to 
predict class membership based on the multinomial logis-
tic regression.26
The computerized software package IBM SPSS 23.0 
performed all other statistical analyses. Shapiro–Wilk test 
was used to assess normality of continuous data. Gaussian- 
shaped distributions were expressed as mean and standard 
deviation. Non-normally distributed continuous data were 
expressed as median and interquartile range. The change 
of QoL within treatment group was analyzed by linear 
mixed modelling. Within mixed modeling, custom hypoth-
esis tests were used to assess differences between the 
follow-up measurements. One-sample t tests were used to 
compare the mean QoL and HS estimates to corresponding 
estimates in the general elderly population. A p-value 
below 0.05 (two-sided) indicated a statistically significant 
result.
Results
Between January 2012 and February 2016, 195 patients 
were included in this study and 192 patients were excluded 
from this study. There were 187 exclusions due to cogni-
tive impairment or refusal to participate; five patients were 
excluded based on primary amputation.11 Included patients 
were divided into three treatment groups.11 Patients were 
treated with endovascular revascularization (n=82), surgi-
cal revascularization (n=67), or they received conservative 
therapy (n=46).
Patient Characteristics
The baseline characteristics are presented in Table 1. Of the 
195 patients, 56% were male and 33% had a Rutherford 






Median age (IQR) 80 (75, 84)
Rutherford class
Category 4 64 (33)








Diabetes mellitus 94 (48)
Renal impairment 111 (57)
Currently smoking 45 (23)
Preoperative risk scores
ASA score 2 53 (27)
ASA score 3 124 (64)
ASA score 4 18 (9)
V-POSSUM score
Median morbidity (IQR) 55 (35, 73)
Median mortality (IQR) 15 (8, 25)
Primary Treatment
Surgical revascularization 67 (34)
Endovascular revascularization 82 (42)
Conservative treatment 46 (24)
Note: Data are presented as number of patients and (%), unless otherwise specified.
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classification of 4. The median age was 80 years old. 
Patients selected for surgical treatment were significantly 
younger (p=0.001) and had less comorbidity compared to 
patients selected for endovascular revascularization and 
conservative therapy. Patients who received conservative 
therapy had significantly higher preoperative risk scores 
(ASA-score).11 The baseline characteristics for the treat-
ment groups separately of this study were previously pub-
lished by Steunenberg et al.11 The flow chart (Figure 1) 
provides an overview of the clinical course of the patients 
included in our study. The overall two-year mortality was 
42.1%. At the two-year follow-up measurement point, 97 
patients were eligible for outcome determination. For 31 
patients out of the initial cohort of 195 patients, there was no 
follow-up data available for QoL and HS questionnaires 
because of loss to follow-up (mostly due to inability to 
complete the questionnaires). Yet, the medical follow-up 
data was available for all patients.
Long-term Outcome
Quality of Life
Figure 2 presents the QoL of patients after one and two years 
of follow-up. The one-year results were previously published 
by Steunenberg et al.27 The overall QoL scores were signifi-
cantly improved at the two-year follow-up measurement 
when compared to the baseline measurement in the surgically 
treated group and in the group receiving conservative treat-
ment (respectively, 3.7 vs 3.0, 95%CI: 0.34–0.83, p<0.001 
and. 3.3 vs 3.1, 95%CI: 0.00–0.78, p=0.049).
After two years, physical QoL had a significantly higher 
score than the baseline measurement in all treatment groups: 
endovascular treatment (13.7 vs 10.9, 95%CI: 1.74–3.63, 
Figure 1 Screened and Included Patients.
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p<0.001), surgical treatment (15.0 vs 10.4, 95%CI: 3.64– 
5.28, p<0.001), and conservative treatment (13.8 vs 11.6, 
95%CI: 1.14–3.88, p<0.001). However, the psychological 
QoL only showed significant improvement in the surgically 
treated group at two-year follow-up (15.3 vs 14.0, 95%CI: 
0.68–1.89, p<0.001). Moreover, there were also no statisti-
cally significant differences between the treatment groups for 
all QoL measurements at two-year follow-up.
In Table 2, the mean QoL scores at baseline and two-year 
follow-up are compared to the mean estimated normal scores 
Figure 2 Quality of Life. Data is presented as mean and standard deviation. *Significant difference between the treatment group and the surgical treatment group (p<0.05). 
**Significant difference in the treatment group between this measurement and baseline (p<0.05).
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Table 2 WHOQOL-BREF Compared to Normal Values for Elderly
n Mean 
Estimate








Total cohort 193 3.086 −0.815 −0.936; −0.693 <0.001
Endovascular group 81 3.105 −0.795 −0.992; −0.598 <0.001
Surgery group 67 3.045 −0.855 −1.067; −0.643 <0.001
Conservative group 45 3.111 −0.789 −1.024; −0.554 <0.001
Physical 14.869
Total cohort 192 10.903 −3.966 −4.362; −3.570 <0.001
Endovascular group 81 10.899 −3.970 −4.604; −3.337 <0.001
Surgery group 65 10.422 −4.447 −5.074; −3.819 <0.001
Conservative group 46 11.589 −3.280 −4.137; −2.422 <0.001
Psychological 14.871
Total cohort 195 14.088 −0.783 −1.129; −0.437 <0.001
Endovascular group 82 14.175 −0.696 −1.239; −0.154 0.012
Surgery group 67 13.967 −0.904 −1.498; −0.310 0.003
Conservative group 46 14.109 −0.762 −1.501; −0.023 0.43
Social relationship 15.251
Total cohort 191 15.467 0.218 −0.1498; 0.586 0.244
Endovascular group 80 15.500 0.249 −0.312; 0.810 0.380
Surgery group 65 15.426 0.174 −0.416; 0.764 0.557
Conservative group 46 15.478 0.227 −0.656; 1.109 0.006
Environment 15.573
Total cohort 188 15.479 −0.093 −0.386; 0.200 0.531
Endovascular group 79 15.443 −0.130 −0.590; 0.331 0.577
Surgery group 63 15.564 −0.009 −0.478; 0.459 0.969
Conservative group 46 15.427 −0.146 −0.816; 0.524 0.664
QoL domains at two-year 
follow-up
Overall 3.90
Total cohort 87 3.512 −0.388 −0.545; −0.231 <0.001
Endovascular group 28 3.375 −0.525 −0.865; −0.185 0.004
Surgery group 43 3.651 −0.249 −0.422; −0.076 0.006
Conservative group 13 3.346 −0.554 −1.038; −0.070 0.028
Physical 14.869
Total cohort 84 14.364 −0.505 1.094; 0.084 0.092
Endovascular group 28 13.704 −1.165 −2.341; 0.011 0.052
Surgery group 43 14.950 0.081 −0.698; 0.860 0.834
Conservative group 13 13.846 −1.023 −2.419; 0.374 0.137
Psychological 14.871
Total cohort 84 15.071 0.200 −0.226; 0.627 0.353
Endovascular group 28 14.810 −0.062 −0.904; 0.781 0.882
Surgery group 43 15.302 0.431 −0.144; 1.006 0.138
Conservative group 13 14.872 0.001 −1.131; 1.133 0.999
Social relationship 15.251
Total cohort 83 16.137 0.885 0.466; 1.305 <0.001
Endovascular group 28 15.405 0.153 −0.830; 1.137 0.751
Surgery group 42 16.508 1.277 0.810; 1.703 <0.001
(Continued)
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in the elderly population.28 At baseline, physical QoL and 
psychological QoL were significantly lower than the normal 
values of elderly. There was no significant difference between 
physical QoL, psychological QoL or environmental two-year 
results and the corresponding normal values for elderly for all 
treatment groups. The overall QoL score was significantly 
lower in comparison with normal value for elderly at baseline 
and at two-year follow-up. The two-year social relationships 
score was significantly higher in comparison with normal 
value for elderly.
Health Status
HS after one-year and two-year follow-up is presented in 
Figure 3. After two years, physical HS (SF-12) significantly 
improved compared to the one-year follow-up measurement 
(37.3 vs 28.0, 95%CI: 2.75–7.25, p<0.001) and to the base-
line measurement (42.5 vs 28.0, 95%CI: 10.48– 16.58, 
p<0.001) in the surgical revascularization group. The physi-
cal HS (SF-12) significantly improved compared to the base-
line measurement in the endovascular group (37.4 vs 28.9, 
95%CI: 2.53–9.46, p=0.001). For all treatment groups, the 
mental HS scores were significantly better than the baseline 
measurement. The mental HS scores were also improved in 
comparison with the one-year follow-up measurement: endo-
vascular treatment (46.8 vs 42.5, 95%CI: 1.90–7.63, 
p=0.001), surgical treatment (51.5 vs 43.9, 95%CI: 4.53– 
9.38, p<0.001), and conservative treatment (45.8 vs 39.5, 
95%CI: 1.05– 9.62, p=0.009).
The scores of the physical and mental domains of the 
SF-12 questionnaire were compared to the mean estimated 
normal scores in the elderly population (Table 3).29 At 
baseline, both domains of the SF-12 were significantly 
impaired in the elderly CLTI population of this study. 
After two years, only surgically treated patients had physi-
cal HS scores corresponding with the scores of their peers.
Trajectories
The number of latent trajectory classes was found to be four 
for the QoL domains and five for the HS domains based on 
the lowest AIC3-value (Supplement Table A). Trajectories 
of the QoL domains are presented in Figure 4 and trajec-
tories of the HS domains are presented in Figure 5. In 
Supplement Tables B1 and B2, an overview of the associa-
tions between the latent trajectory classes and the socio-
demographic and clinical characteristics is provided for the 
overall, physical and psychological domains of QoL and the 
physical and mental domains of HS. Because of the large 
number of tested associations, a Bonferroni correction was 
applied resulting in an adjusted significance level of 0.05/14 
predictors=0.0035. Overall, there were no overlapping risk 
factors for poorer QoL and/or HS in this patient population.
Discussion
Although QoL and HS are discussed for CLTI patients in 
current literature,11–13,30–32 there is a paucity of information 
about long-term QoL and HS outcomes in elderly CLTI 
patients. In our study, there is a persistent gain in QoL and 
HS for the surgically treated patients after two years. For all 
treatment groups, the physical QoL is significantly better 
compared to the baseline measurement in the long-term. 
Concerning physical HS, both surgically and endovascular 
treated patients improve significantly on this domain of the 
SF-12. Interestingly, conservatively treated patients do not 
show any improvements on their physical HS scores during 
two years of follow-up. More importantly, physical QoL did 
not differ from the corresponding normal values for patients in 
all treatment groups after two-years of follow-up.28 But then 
again, the overall QoL score was significantly lower in com-
parison with normal value for elderly after two years of 
follow-up.
Table 2 (Continued). 
n Mean 
Estimate






Conservative group 13 16.513 1.261 0.437; 2.086 0.006
Environment 15.573
Total cohort 84 15.643 0.070 −0.240; 0.380 0.653
Endovascular group 28 15.571 −0.001 −0.576; 0.574 0.997
Surgery group 43 15.721 0.148 −0.286; 0.583 0.494
Conservative group 13 15.539 −0.034 −0.919; 0.851 0.934
Notes: Data presented as mean; a p-value of <0.05 represents a significant difference between the mean value of the general elderly population and the value in this cohort 
(indicated with bold front). The value of the general elderly population is based on reference 28.
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Our results are only partly in line with previous studies 
conducted with CLTI patients. The BASIL trial stated that 
both endovascular and surgical revascularization led to an 
improved long-term QoL.12 In our study, the surgically 
treated rose in QoL scores and endovascular treated 
patients only gained in physical QoL. A possible explana-
tion for this might be that patients were included in our 
study despite comorbidities or type of anatomic lesion. 
Due to the latter, patients could only be randomized in 
the BASIL trial if patients were suited for open or 
Figure 3 Health status (SF-12). Data is presented as mean and standard deviation. *Significant difference between the treatment group and the surgical treatment group 
(p<0.05). **Significant difference in the treatment group between this measurement and baseline (p<0.05). ***Significant difference in the treatment group between this 
measurement and the 12-month measurement (p<0.05).
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endovascular revascularization. Thus, only half of the 
elderly patients with infra-inguinal lesions could be 
included in the BASIL trial. Similar to our study, a sig-
nificant difference in QoL between the two groups could 
not be detected.12,33 Still, it remains uncertain whether the 
BASIL trial’s QoL results reflect the underlying QoL. It 
can be argued that the disease-specific VascuQol question-
naire does not represent QoL. The measurement of physi-
cal function in the VascuQol questionnaire represents an 
“objective” assessment of performing activities instead of 
the patient’s perception of his overall functioning.34 
Therefore, the VascuQol questionnaire is an objective 
assessment of functioning eg HS.4 In addition, the differ-
entiating power in CLTI patients is deficient and therefore 
it may not be applicable to the CLTI patient group.35
Van Hattem et al indicated that HS deteriorates after 
peripheral bypass surgery in the long-term (mean follow-up 
11 years).13 There is a lack of other studies on the long-term 
HS of CLTI patients. In our study, surgically and endovas-
cular treated patients show a significant improvement of 
physical and mental HS after two years of follow-up. 
Patients who received conservative treatment do not show 
any deterioration in the physical and mental HS domains 
during two years of follow-up. This study indicated that 
surviving patients do not experience worse HS two years 
after the start of any treatment.
An understanding of the profile of elderly CLTI 
patients to identify patients with factors that could 
impair QoL and HS was lacking. In the latent class 
analysis, patients with the lowest and highest QoL and 
HS trajectories could be identified. The findings of this 
prospective observational cohort study may help us 
recognize elderly CLTI patients that may need a careful 
reconsideration of the intended treatment. Consequently, 
a tailored approach in the management of CLTI can be 
facilitated when there is insight into the variables that 
make a patient prone to better or worse QoL or HS 
outcomes. With respect to shared decision making, 
these distinctive variables will provide a very important 
facet in personalized medicine.
In patients with IC, prior reports have focussed on 
factors that might influence the course of HS. Poorer HS 
Table 3 HS Compared to Normal Values for Elderly
n Value Value of General  
Elderly Population
Mean Difference p-value 95%CI
Baseline HS domains
Physical 44.22
Total cohort 190 28.87 −15.35 <0.001 −16.596; −14.097
Endovascular group 78 28.88 −15.34 <0.001 −17.427; 13.256
Surgery group 66 27.98 −16.24 <0.001 −17.880; −14.608
Conservative group 46 30.15 −14.07 <0.001 −17.140; −10.999
Mental 47.71
Total cohort 190 37.44 −4.58 <0.001 11.863; −8.670
Endovascular group 78 36.98 −10.73 <0.001 −13.376; −8.090
Surgery group 66 36.13 −11.57 <0.001 −14.103; −9.054
Conservative group 46 40.12 −7.59 <0.001 −10.914; −4.272
HS domains at two-year  
follow-up
Physical 44.22
Total cohort 84 39.64 −10.27 <0.001 −6.984; 2.186
Endovascular group 28 37.39 −6.83 0.005 −11.381; −2.275
Surgery group 43 42.53 −1.69 0.287 −4.854; 1.474
Conservative group 13 34.89 −9.33 0.005 −15.345; −3.312
Mental 47.71
Total cohort 84 49.07 1.36 0.209 −0.774; 3.490
Endovascular group 28 46.78 −0.93 0.667 −5.320; 3.457
Surgery group 43 51.54 3.83 0.004 1.289; 6.376
Conservative group 13 45.81 −1.90 0.496 −7.778; 3.984
Notes: Data presented as mean; a p-value of <0.05 represents a significant difference between the mean value of the general elderly population and the value in this cohort 
(indicated with bold front). The value of the general elderly population is based on reference 29.
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in these patients was associated with younger age, 
female sex, the presence of cardiac disease, worsening 
ankle-brachial index and not having a partner.15,36–38 
However, these results do not apply to the elderly 
CLTI patients in this study. No sociodemographic or 
clinical variables significantly influenced the lowest 
QoL and HS trajectories.
Our study has limitations. Firstly, in this observational 
study, patients were not randomized to treatment. Thereby, 
this study suffers from selection bias. Nevertheless, a selection 
Figure 4 Quality of Life Trajectories.
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bias even exists when CLTI patients are randomized to treat-
ment. Not all patients are suitable for both surgical and endo-
vascular revascularization. Moreover, some patients cannot 
undergo either of these treatments. So in this study, the treat-
ment selection after counselling in a multidisciplinary vascular 
conference resembles current clinical practice. Secondly, in 
this study questionnaires were conducted. In survey research 
a non-response bias is always present. The main reason for loss 
to follow-up was incapability of completing questionnaires 
during follow-up. Still, response rates were high when com-
pared to the BASIL trial and PREVENT trial. At two years 
follow-up 84.1% patients alive completed the questionnaires. 
In the BASIL trial, the response rate was 70%.12 Response rate 
was similar in the PREVENT trial; 62.5% at one-year follow- 
up.39 Thirdly, patients with primary amputations were 
excluded due to the low number of patients (n=5). Therefore, 
this study was underpowered to examine the clinical outcome 
of patients with a primary amputation. Future research will 
examine QoL and HS of primarily amputated CLTI patients. In 
addition, due to of the small number of surviving patients, this 
study did not differentiate between patients with ischemic rest 
pain and patients with ischemic ulcers or wounds. Previously 
published data of this study shows that patients with ischemic 
ulcers or wounds were significantly less treated with conserva-
tive treatment compared to revascularization.11 In future 
research, a differentiation should be made between patients 
with ischemic rest pain and patients with ischemic ulcers or 
wounds.
Figure 5 Health Status Trajectories.
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Currently, long-term outcome in elderly CLTI patients are 
lacking.40 This study shows that physical and psychological 
QoL levels in surviving elderly CLTI patients do not differ 
from the corresponding normal values of elderly people. 
Moreover, physical QoL increases after revascularization 
and conservative treatment after two years of follow-up. 
Physical HS only improves in revascularized patients. This 
was also the first study to evaluate the trajectory of elderly 
CLTI patients’ QoL or HS after treatment. Interestingly, no 
sociodemographic or clinical variables significantly influ-
enced the lowest QoL and HS trajectories. It is hoped that 
this study encourages further analysis of the influence of 
biopsychosocial characteristics on QoL and HS in elderly 
CLTI patients in order to achieve personalized medicine and 
aid the shared decision making process.
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